Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Vonlerolizumab Biosimilar – Anti-TNFRSF4, CD134 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG1, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade |
|---|---|
| Source | CAS 1638935-72-4 |
| Species | Humanized |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Vonlerolizumab,MOXR-0916,MOXR0916,RG-7888,RO7021608,TNFRSF4, CD134,anti-TNFRSF4, CD134 |
| Reference | PX-TA1424 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Vonlerolizumab Biosimilar - Anti-TNFRSF4, CD134 mAb - Research Grade
General information on Anti-TNFRSF4/CD134[Homo sapiens] (Vonlerolizumab) Monoclonal Antibody
Vonlerolizumab is investigated for thr treatment of Locally Advanced or Metastatic Urothelial Carcinoma.
Related products
Antigen
Human OX40 recombinant protein
PX-P6017 420€Contact us
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.